Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03943082 · ClinicalTrials.gov registry record · NA
Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT03943082: Clinical Trial NA study, sponsored by University of California, San Francisco.
NCT03943082 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 252 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03943082, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
This trial studies how well a follow-up phone call regarding financial reimbursement program (FRP) works in improving cancer patients' access to therapeutic cancer clinical trials. Follow-up phone call intervention regarding FRP may improve recruitment of cancer patients to cancer therapeutic clinical trials.
Primary Outcome
The point estimate and 95% confidence interval (CI) of the proportion will be obtained within each site, furthermore, by cancer type and by phase of the clinical trial within each site.
Interventions
- BEHAVIORAL Questionnaire
- OTHER Follow-Up Care
- BEHAVIORAL Cancer Educational Materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2019-04-08 |
| Est. Completion | 2021-10-26 |
| Phase | NA |
Why NCT03943082 stopped before completion
NCT03943082 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 3 interventions - of which Questionnaire is the first listed.
NCT03943082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03943082 about?
NCT03943082 is a clinical study titled "Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials". This trial studies how well a follow-up phone call regarding financial reimbursement program (FRP) works in improving cancer patients' access to therapeutic cancer clinical trials. Follow-up phone call intervention regarding FRP may improve recruitment of cancer patients to cancer therapeutic clinic...
What is the current status of trial NCT03943082?
This trial is currently terminated. It is a NA study. The enrollment target is 252 participants. The study started on 2019-04-08. Estimated completion is 2021-10-26.
What interventions are being tested in trial NCT03943082?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Follow-Up Care (OTHER), Cancer Educational Materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT03943082?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03943082's enrollment target sits among peer trials
252 407th of 2000 higher than 1,591 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI